Lv1
30 积分 2022-03-11 加入
Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors
2个月前
已完结
Immunogenicity risk mitigation of therapeutic proteins with translational immunogenicity, analytical characterization, and regulatory insight
3个月前
已完结
Ocular toxicities associated with antibody drug conjugates and immunotherapy in oncology: clinical presentation, pathogenesis, and management strategies
4个月前
已完结
SDP-LIV1, a Novel and Optimized LIV-1 Antibody-drug Conjugate Demonstrating Superior Anti-Tumor Efficacy and Favorable Safety Profile for Treatment of Solid Tumors
4个月前
已完结
Function of TRPC1 in modulating hepatocellular carcinoma progression
6个月前
已完结
Catumaxomab: First Approval
7个月前
已关闭
皖公网安备34019202002308
